Modulation of Th1/Th2 balance by infliximab rescues postoperative occurrence of small-intestinal inflammation associated with ulcerative colitis. [electronic resource]
Producer: 20100707Description: 1781-4 p. digitalISSN:- 1573-2568
- Adult
- Anti-Inflammatory Agents -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Biopsy
- Colitis, Ulcerative -- diagnosis
- Colonic Pouches -- adverse effects
- Digestive System Surgical Procedures -- adverse effects
- Duodenitis -- diagnosis
- Duodenum -- drug effects
- Endoscopy, Digestive System
- Female
- Gastrointestinal Agents -- therapeutic use
- Humans
- Ileostomy -- adverse effects
- Infliximab
- Pouchitis -- drug therapy
- Proctocolectomy, Restorative -- adverse effects
- Recurrence
- Th1 Cells -- drug effects
- Th2 Cells -- drug effects
- Tomography, X-Ray Computed
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.